SciELO - Scientific Electronic Library Online

 
vol.30 issue2Histoplasmose em pacientes imunodeprimidos: estudo de 18 casos observados em Uberlândia, MGLimiar anaeróbio detectado pela "análise da curva-V" na cardiopatia chagásica crônica author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682

Abstract

SAMPAIO, Raimunda Nonata Ribeiro  and  MARSDEN, Phillip Davis. Tratamento da forma mucosa de leishmaniose sem resposta a glucantime, com anfotericina B liposomal. Rev. Soc. Bras. Med. Trop. [online]. 1997, vol.30, n.2, pp. 125-128. ISSN 0037-8682.  http://dx.doi.org/10.1590/S0037-86821997000200007.

We treated six patients with mucosal leishmaniasis who failed to respond to glucantime (20mg/kg/day) with ambisome (2-5 grams total dose). The daily dose was 2-3mg/kg/day given for a minimum of 20 days. After 26-38 months of follow up, five patients were clinically cured. One relapsed after six months. No side effects of therapy were observed apart from headache after injection. Ambisome is a therapeutic option for patients with mucosal leishmaniasis unresponsive to antimonials.

Keywords : Mucosal leishmaniasis; Leishmania (Viannia) braziliensis; Amphotericin B liposome.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese